Publiziert in: Marktpuls, Unternehmen
Frei

Invitation to Roche's Virtual Investor Event at EASD Freitag, 23. August 2024 - 11:50

Investor Update  ?v=11232021124200
Invitation to Roche's Virtual Investor Event at EASD
 

image1.png

 

We are pleased to invite investors and analysts to participate in our virtual event on Friday, 13 September 2024, highlighting Roche data presented at the European Association for the Study of Diabetes 2024 Meeting, from 9 - 13 September 2024.

 

16:00 – 17:30 CEST / 15:00 - 16:30 BST

10:00 – 11:30 am EDT / 7:00 – 8:30 am PDT

 

The webinar will start with a presentation, followed by a Q&A session (live access to the speakers). The slides will be available for download at 15:00 CEST on the day of the event.
> click here

 

Access to virtual event (pre-registration required)

Please pre-register for our webinar here*.

 

Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to investor.relations@roche.com.

 

A replay of the webcast will be available via > ir.roche.com

 

*privacy notice

 

Best regards,

 

Bruno Eschli
Head of Investor Relations

 

 

 


Roche Investor Relations

 

Dr. Bruno Eschli

Phone: +41 61 68-75284

e-mail: bruno.eschli@roche.com

 

Dr. Sabine Borngräber

Phone: +41 61 68-88027

e-mail: sabine.borngraeber@roche.com

 

Dr. Birgit Masjost

Phone: +41 61 68-84814

e-mail: birgit.masjost@roche.com

 

 

 

 

Investor Relations North America

 

Loren Kalm

Phone: +1 650 225 3217

e-mail: kalm.loren@gene.com

 

 

 

 

All rights reserved ©2024 F. Hoffmann-La Roche Ltd.
Group Communications, Grenzacherstrasse 124, CH-4070 Basel, Switzerland